» Articles » PMID: 18768112

Improved Predictive Model for Pre-symptomatic Mild Cognitive Impairment and Alzheimer's Disease

Overview
Journal Neurol Res
Specialty Neurology
Date 2008 Sep 5
PMID 18768112
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Delineation of gray matter (GM) structures on brain MRI scans is termed segmentation. Accuracy of segmentation is a key factor in the valid comparison of GM density and volume between individuals and groups. Previously, it was demonstrated that a group of normal subjects who later developed mild cognitive impairment (MCI) had decreased GM volume in the medial temporal lobe compared to other normal subjects who remained normal an average 5.4 years after the scan. The objective of this study was to show whether accuracy of this predictive model was increased using an advanced segmentation technique.

Methods: Structural MRI was performed on 74 longitudinally examined normal aged subjects. All subjects were cognitively normal at the time of their scan, but 18 later developed MCI, and six of these 18 went on from MCI to an AD diagnosis. We independently delineated GM using both a standard segmentation technique and a local Gaussian active contour (LGAC) technique. We compared the contribution of extracted volumes from each technique to a model predicting subjects who will eventually develop MCI.

Results: Accuracy of the standard technique to distinguish pre-MCI from normal using imaging alone was 79% (sensitivity 78% and specificity 73%). Using LGAC, accuracy rose to 84% (sensitivity 78% and specificity 84%).

Discussion: Structural brain changes precede MCI in longitudinally followed normal subjects. The LGAC technique improves the accuracy of a predictive model incorporating these structural changes by improving GM segmentation and the specificity of the model.

Citing Articles

Epigenetic changes in the progression of Alzheimer's disease.

Bradley-Whitman M, Lovell M Mech Ageing Dev. 2013; 134(10):486-95.

PMID: 24012631 PMC: 3857018. DOI: 10.1016/j.mad.2013.08.005.


Preclinical Alzheimer disease: identification of cases at risk among cognitively intact older individuals.

Lazarczyk M, Hof P, Bouras C, Giannakopoulos P BMC Med. 2012; 10:127.

PMID: 23098093 PMC: 3523068. DOI: 10.1186/1741-7015-10-127.


Structural imaging in early pre-states of dementia.

Smith C Biochim Biophys Acta. 2011; 1822(3):317-24.

PMID: 21777674 PMC: 3223541. DOI: 10.1016/j.bbadis.2011.07.002.


Elevated 4-hydroxyhexenal in Alzheimer's disease (AD) progression.

Bradley M, Xiong-Fister S, Markesbery W, Lovell M Neurobiol Aging. 2010; 33(6):1034-44.

PMID: 20965613 PMC: 3025307. DOI: 10.1016/j.neurobiolaging.2010.08.016.


Increased protein hydrophobicity in response to aging and Alzheimer disease.

Dasuri K, Ebenezer P, Zhang L, Fernandez-Kim S, Bruce-Keller A, Markesbery W Free Radic Biol Med. 2010; 48(10):1330-7.

PMID: 20188163 PMC: 3175611. DOI: 10.1016/j.freeradbiomed.2010.02.012.